Review Article
Association between Hypertension and Periodontitis: Possible Mechanisms
Table 2
Studies reporting inflammatory involvement in the interrelationship between hypertension and periodontitis.
| Study | Design | Periodontal evaluation | Inflammatory markers | Hypertension-related parameters | Key findings |
| Higashi et al. 2009 [65] | Prospective | PPD CAL GB | CRP IL-6 | Forearm blood flow responses to vasoactive substances, SBP and DBP | Periodontitis is associated with reduced NO bioavailability and ED, with systemic inflammation as a predictor of ED |
| Papapanagiotou et al. 2009 [66] | Case-control | Reported periodontitis | Leukocyte counts Platelet count CRP P-selectin | SBP and DBP | Periodontitis is associated with platelet activation |
| Herrera et al. 2011 [67] | Experimental | X-ray bone loss assessment | MPO TBARS NT | NO | NO contributes to the systemic effects of periodontitis |
| Eder et al. 2012 [68] | Case-control | Radiography (WHO) | PGE2ā TXB2 | PGI2 | Presence of granuloma in periodontitis is linked to inflammation and the synthesis of metabolites of AA |
| Brito et al. 2013 [69] | Experimental | Measurement of alveolar bone loss of mandibles | Leukocyte counts IL-6 CRP | Mean arterial pressure, vascular reactivity | Periodontitis induces systemic and vascular inflammation which lead to ED |
|
|
AA: arachidonic acid; CAL: clinical attachment loss; CRP: C-reactive protein; DBP: diastolic blood pressure; ED: endothelial dysfunction; GB: gingival bleeding; IL: interleukin; MPO: myeloperoxidase; NO: nitric oxide; NT: nitrotyrosine-containing protein; PGE2: prostaglandin E2; PGI2: prostacyclin; PPD: probing pocket depth; SBP: systolic blood pressure; TBARS: thiobarbituric acid reactive substances; TXB2: thromboxane B2; WHO: World Health Organisation.
|